Whole-exome sequencing of matched blood, primary GBM tumours, and patient-derived organoids
Whole-exome sequencing (~250X coverage) of primary GBM tumours and matched patient-derived organoids and normal blood. Samples from two spatially distinct regions of seven tumours from five patients (five primary, two recurrent).
- 29 samples
- DAC: EGAC00000000011
- Technology: Illumina HiSeq 2500
- RU DUO:0000014 (version: 2019-01-07)research use onlyThis data use limitation indicates that use is limited to research purposes (e.g., does not include its use in clinical care).
BCCA (BCGSC) data policy
This document refers to the data set which has been submitted to the European Genome Archive (EGA) for the controlled access by legitimate academic institutions that have agreed to comply with the terms of a Data Access Agreement drafted by the British Columbia Cancer Agency Branch herein represented by the Technology Development Office of the Provincial Health Services Authority. There are a number of steps that a researcher must take to obtain access to this data and the process is overseen by the Technology Development Office - contact our general email address TDOadmin@phsa.ca
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
|Study ID||Study Title||Study Type|